Home
About
Overview
Sharing Data
ORCID
Help
History (1)
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer? Ther Adv Med Oncol. 2023; 15:17588359231198446.
View in:
PubMed
authors with profiles
Jessica Donington
James Dolezal
Everett Vokes
Marina Chiara Garassino
Christine Bestvina